Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002040417 | SCV002299472 | likely pathogenic | Fanconi anemia | 2021-08-12 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 8 of the FANCC gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of Fanconi anemia (PMID: 17924555, 30031030). Studies have shown that disruption of this splice site results in skipping of exon 9 and introduces a premature termination codon (PMID: 30031030). The resulting mRNA is expected to undergo nonsense-mediated decay. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |